Cboe US - Delayed Quote USD

Franklin Genomic Advancements ETF (HELX)

31.66 -0.12 (-0.39%)
At close: May 15 at 12:48 PM EDT
Loading Chart for HELX
DELL
  • Previous Close 31.65
  • Open 31.91
  • Bid 15.81 x 800
  • Ask 47.41 x 900
  • Day's Range 31.66 - 31.66
  • 52 Week Range 25.26 - 32.92
  • Volume 67
  • Avg. Volume 788
  • Net Assets 9.02M
  • NAV 31.69
  • PE Ratio (TTM) 20.66
  • Yield 0.00%
  • YTD Daily Total Return 3.91%
  • Beta (5Y Monthly) 1.15
  • Expense Ratio (net) 0.50%

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Franklin Templeton Investments

Fund Family

Health

Fund Category

9.02M

Net Assets

2020-02-25

Inception Date

Performance Overview: HELX

Trailing returns as of 5/17/2024. Category is Health.

YTD Return

HELX
3.91%
Category
0.45%
 

1-Year Return

HELX
6.34%
Category
1.63%
 

3-Year Return

HELX
8.04%
Category
3.64%
 

People Also Watch

Holdings: HELX

Top 10 Holdings (43.79% of Total Assets)

SymbolCompany% Assets
MEDP
Medpace Holdings, Inc. 7.91%
TMO
Thermo Fisher Scientific Inc. 4.97%
VRTX
Vertex Pharmaceuticals Incorporated 4.72%
REGN
Regeneron Pharmaceuticals, Inc. 4.51%
LLY
Eli Lilly and Company 4.22%
DHR
Danaher Corporation 4.18%
KRYS
Krystal Biotech, Inc. 4.01%
BRKR
Bruker Corporation 3.18%
NTRA
Natera, Inc. 3.09%
207940.KS
Samsung Biologics Co.,Ltd. 3.01%

Sector Weightings

SectorHELX
Healthcare   94.60%
Technology   2.27%
Real Estate   0.32%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: HELX

Research Reports: HELX

Related Tickers